POSTPONED: Advanced Heart Failure Symposium

Inova's annual Advanced Heart Failure Symposium, normally held in the fall, has been postponed until 2021. We look forward to seeing our valued attendees and sponsors next year.
closeup of diagnostic imaging of heart

CANCELLED: 2020 Cardiovascular Symposium

Following recent reports from the WHO and CDC and due to the increasing number of travel bans being placed on health care providers, hospitals and institutions, out of an abundance of caution, we have made the necessary decision to cancel the 2020 Inova Cherry Blossom Cardiovascular Symposium.
Read more
abstract heart image
 

Cardiology Grand Rounds: The Inova Dudley Family Center Visiting Professor Series

(Usually 2nd Tuesday of the month)
Target audience: Members of the medical staff (all sub-specialties, medical residents and students)
Lecture from 12:30 - 1:30 p.m.

Dr. Kenneth Mahaffey

Tuesday, August 11, 2020:

Kenneth W. Mahaffey, MD

Professor, Cardiovascular Medicine
Associate Dean, Clinical Research, School of Medicine, Stanford University
Vice Chair, Clinical Research, Department of Medicine, Stanford University
Director, Stanford Center for Clinical Research

This event will be held online. Meeting information is below.

Join Zoom Meeting: https://inova.zoom.us/j/93146609731?pwd=Vk1RSTQ1V2NyOGlEY1QvMUZxZlR2QT09 

Meeting ID: 931 4660 9731
Password: 183789

One tap mobile
+19292056099,,93146609731#,,,,0#,,183789# US (New York)
+13017158592,,93146609731#,,,,0#,,183789# US (Germantown)
 

The Project Baseline Health Study: Building a Science Platform and a Participant Community

Objectives:

  1. Describe the rationale and design of the Project Baseline Health Study
  2. Describe the baseline characteristics
  3. Discuss the importance of participant engagement in the research process

Kenneth W. Mahaffey, MD, is the Vice Chair of Clinical Research in the Department of Medicine at Stanford University and the Director of the Stanford Center for Clinical Research (SCCR). SCCR is an academic research organization that supports researchers as they design and conduct clinical research studies and enroll Stanford patients in clinical trials. SCCR has expertise in mobile and digital technology investigation. Dr. Mahaffey’s own research focuses on the design and conduct of multicenter clinical trials and analyses of important clinical cardiac issues using large patient databases. His research efforts have resulted in the approval of new therapies for the treatment of patients with acute coronary syndromes, diabetes and atrial fibrillation.

Dr. Mahaffey also studies the methodology of clinical trials including the standardization of the definition of myocardial infarction (MI) used in clinical trials, the adjudication of clinical endpoints and the evaluation of evidence-based operations. He works with the FDA and chaired the MI and Death Definitions Working Group in the Standardized Data Collection for Cardiovascular Trials Initiative. Dr. Mahaffey is a member of the Stanford University Institutional Review Board.

This is a CME Accredited Program.

See all previous speakers of the Inova Dudley Family Center Visiting Professor Series arrows

2020 IHVI Grand Rounds Speakers

January   Michael R. Bristow, MD, PhD, FACC, FAHA
February   G. Michael Felker, MD, MHS, FACC, FAHA, FHFSA
March   Richard F. Neville, MD, DFSVS
June   Christopher M. Kramer, MD
July   Anthony Comerota, MD
August   Kenneth W. Mahaffey, MD
September   Vineet Kumar, MD
October   James de Lemos, MD
November   Joann Lindenfeld, MD
December   Mandeep Mehra, MD FRCP

Join the IHVI Center for Education Community

At Inova Heart and Vascular Institute we are dedicated to providing informative and thought provoking education with physicians, nurses, and medical professionals worldwide. Our activities are designed to enhance the professional development of the medical community by providing high-quality, innovative educational programs that improve clinical performance, and promote life-long learning. Through lectures, case studies, and participant-faculty interactions, attendees will be exposed to cutting-edge educational content and the latest advances in cardiology.




Top of page